Edwards Lifesciences Corp (EW) › Capital ExpendituresEdwards Lifesciences Corp (EW) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2008: $50.60M2009: $64.00M2010: $61.80M2011: $76.60M2012: $109.00M2013: $109.00M2014: $82.90M2015: $102.70M2016: $176.10M2017: $168.10M2018: $238.70M2019: $254.40M2020: $407.00M2021: $325.80M2022: $244.60M2023: $253.00M2024: $252.40M2025: $260.20M$260.20M2008Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$260.20M+3.1%2024$252.40M-0.2%2023$253.00M+3.4%2022$244.60M-24.9%2021$325.80M-20.0%2020$407.00M+60.0%2019$254.40M+6.6%2018$238.70M+42.0%2017$168.10M-4.5%2016$176.10M+71.5%2015$102.70M+23.9%2014$82.90M-23.9%2013$109.00M+0.0%2012$109.00M+42.3%2011$76.60M+23.9%2010$61.80M-3.4%2009$64.00M+26.5%2008$50.60M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share